Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1

Stanislaw R Burzynski,
Gregory S Burzynski,
Tomasz J Janicki,
Samuel W Beenken